Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone binding	RAG1 BAZ1B CHD8 CHD3 NCAPG2 BRD9 SMARCA2 ANP32E CHD6	1.73e-05	265	111	9	GO:0042393
GeneOntologyMolecularFunction	helicase activity	SETX MCM4 CHD8 CHD3 SMARCA2 CHD6 DDX24	2.90e-05	158	111	7	GO:0004386
GeneOntologyMolecularFunction	prostaglandin-endoperoxide synthase activity	PTGS1 PTGS2	3.06e-05	2	111	2	GO:0004666
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CHD8 CHD3 SMARCA2 CHD6	5.19e-05	37	111	4	GO:0140658
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	SETX MCM4 CHD8 CHD3 SMARCA2 CHD6	7.71e-05	127	111	6	GO:0008094
GeneOntologyMolecularFunction	acyltransferase activity	CUL1 RAG1 NAA15 CPT1B SAT2 FBXW8 UBA7 FBXO9 PLA2G4C RNF103 TRIM9 NAT10 RPGR	3.70e-04	775	111	13	GO:0016746
GeneOntologyMolecularFunction	chromatin insulator sequence binding	ZFX ZFY	6.32e-04	7	111	2	GO:0043035
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	RAG1 SETX MCM4 CHD8 CHD3 SMARCA2 CHD6	6.58e-04	262	111	7	GO:0140097
GeneOntologyMolecularFunction	armadillo repeat domain binding	STRN3 CHD8	1.07e-03	9	111	2	GO:0070016
GeneOntologyBiologicalProcess	protein-DNA complex organization	RAG1 PARP2 BAZ1B CHD8 CHD3 POGZ PRDM5 TRRAP ZFY EEF2KMT PBRM1 LMNB1 BRD9 SMARCA2 ANP32E PRKCA CHD6	2.13e-05	999	110	17	GO:0071824
GeneOntologyBiologicalProcess	chromatin organization	RAG1 PARP2 BAZ1B CHD8 CHD3 PRDM5 TRRAP ZFY EEF2KMT PBRM1 LMNB1 BRD9 SMARCA2 ANP32E PRKCA CHD6	2.14e-05	896	110	16	GO:0006325
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	BAZ1B GON4L CHD3 TRRAP PBRM1 BRD9 SMARCA2 ANP32E	3.82e-08	96	109	8	GO:0070603
GeneOntologyCellularComponent	ATPase complex	BAZ1B GON4L CHD3 TRRAP PBRM1 BRD9 SMARCA2 ANP32E	3.81e-07	129	109	8	GO:1904949
GeneOntologyCellularComponent	nuclear chromosome	SETX BAZ1B GON4L MCM4 TRRAP NCAPG2 PBRM1 ANP32E	5.62e-05	254	109	8	GO:0000228
GeneOntologyCellularComponent	cilium	CYLD PDGFRA BEST2 EFCAB2 ACE PTGS1 IFT43 MAGI2 FBXW8 PRKCA RPGR SPAG17 USH2A CNGA2	2.38e-04	898	109	14	GO:0005929
GeneOntologyCellularComponent	INO80-type complex	GON4L TRRAP ANP32E	4.11e-04	28	109	3	GO:0097346
GeneOntologyCellularComponent	SCF ubiquitin ligase complex	CUL1 FBXW8 FBXO9 CACYBP	4.92e-04	70	109	4	GO:0019005
GeneOntologyCellularComponent	SWI/SNF complex	PBRM1 BRD9 SMARCA2	5.05e-04	30	109	3	GO:0016514
GeneOntologyCellularComponent	non-motile cilium	PTGS1 MAGI2 PRKCA RPGR USH2A CNGA2	5.72e-04	196	109	6	GO:0097730
GeneOntologyCellularComponent	photoreceptor cell cilium	PTGS1 MAGI2 PRKCA RPGR USH2A	8.12e-04	139	109	5	GO:0097733
GeneOntologyCellularComponent	9+0 non-motile cilium	PTGS1 MAGI2 PRKCA RPGR USH2A	1.25e-03	153	109	5	GO:0097731
Domain	Transcrp_activ_Zfx/Zfy-dom	ZFX ZFY ZNF711	1.99e-07	3	110	3	IPR006794
Domain	Zfx_Zfy_act	ZFX ZFY ZNF711	1.99e-07	3	110	3	PF04704
Domain	BRK	CHD8 SMARCA2 CHD6	3.92e-06	6	110	3	SM00592
Domain	BRK_domain	CHD8 SMARCA2 CHD6	3.92e-06	6	110	3	IPR006576
Domain	BRK	CHD8 SMARCA2 CHD6	3.92e-06	6	110	3	PF07533
Domain	SNF2_N	CHD8 CHD3 SMARCA2 CHD6	3.61e-05	32	110	4	IPR000330
Domain	SNF2_N	CHD8 CHD3 SMARCA2 CHD6	3.61e-05	32	110	4	PF00176
Domain	BROMODOMAIN_1	BAZ1B PBRM1 BRD9 SMARCA2	6.48e-05	37	110	4	PS00633
Domain	Bromodomain	BAZ1B PBRM1 BRD9 SMARCA2	7.21e-05	38	110	4	PF00439
Domain	BROMODOMAIN_2	BAZ1B PBRM1 BRD9 SMARCA2	9.75e-05	41	110	4	PS50014
Domain	UCP038083_PDZ	GIPC1 GIPC2	1.03e-04	3	110	2	IPR017379
Domain	Bromodomain	BAZ1B PBRM1 BRD9 SMARCA2	1.07e-04	42	110	4	IPR001487
Domain	BROMO	BAZ1B PBRM1 BRD9 SMARCA2	1.07e-04	42	110	4	SM00297
Domain	-	BAZ1B PBRM1 BRD9 SMARCA2	1.07e-04	42	110	4	1.20.920.10
Domain	Chromo_domain	CHD8 CHD3 CHD6	3.68e-04	24	110	3	IPR023780
Domain	Helicase_C	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.27e-04	107	110	5	PF00271
Domain	HELICc	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.27e-04	107	110	5	SM00490
Domain	-	GTPBP4 NUGGC SETX MCM4 CHD8 CHD3 PFKFB4 MFN1 RHOBTB2 SMARCA2 CHD6 DDX24 ABCC10	4.43e-04	746	110	13	3.40.50.300
Domain	Helicase_C	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.45e-04	108	110	5	IPR001650
Domain	P-loop_NTPase	GTPBP4 NUGGC SETX MCM4 CHD8 CHD3 PFKFB4 MFN1 MAGI2 RHOBTB2 SMARCA2 CHD6 DDX24 ABCC10	4.55e-04	848	110	14	IPR027417
Domain	HELICASE_CTER	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.65e-04	109	110	5	PS51194
Domain	HELICASE_ATP_BIND_1	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.65e-04	109	110	5	PS51192
Domain	DEXDc	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.65e-04	109	110	5	SM00487
Domain	Chromo	CHD8 CHD3 CHD6	4.68e-04	26	110	3	PF00385
Domain	Bromodomain_CS	BAZ1B PBRM1 SMARCA2	4.68e-04	26	110	3	IPR018359
Domain	Helicase_ATP-bd	CHD8 CHD3 SMARCA2 CHD6 DDX24	4.84e-04	110	110	5	IPR014001
Domain	FAT	SMG1 TRRAP	5.08e-04	6	110	2	PS51189
Domain	FATC	SMG1 TRRAP	5.08e-04	6	110	2	PS51190
Domain	FATC_dom	SMG1 TRRAP	5.08e-04	6	110	2	IPR003152
Domain	PIK_FAT	SMG1 TRRAP	5.08e-04	6	110	2	IPR014009
Domain	FATC	SMG1 TRRAP	5.08e-04	6	110	2	SM01343
Domain	CHROMO_1	CHD8 CHD3 CHD6	5.85e-04	28	110	3	PS00598
Domain	CHROMO_2	CHD8 CHD3 CHD6	5.85e-04	28	110	3	PS50013
Domain	Chromodomain-like	CHD8 CHD3 CHD6	8.71e-04	32	110	3	IPR016197
Domain	Chromo/shadow_dom	CHD8 CHD3 CHD6	9.54e-04	33	110	3	IPR000953
Domain	CHROMO	CHD8 CHD3 CHD6	9.54e-04	33	110	3	SM00298
Domain	DNA/RNA_helicase_DEAH_CS	CHD8 CHD3 CHD6	1.13e-03	35	110	3	IPR002464
Domain	DEAH_ATP_HELICASE	CHD8 CHD3 CHD6	1.44e-03	38	110	3	PS00690
Domain	An_peroxidase	PTGS1 PTGS2	1.50e-03	10	110	2	PF03098
Domain	Haem_peroxidase_animal	PTGS1 PTGS2	1.50e-03	10	110	2	IPR019791
Domain	Haem_peroxidase	PTGS1 PTGS2	1.50e-03	10	110	2	IPR010255
Domain	PEROXIDASE_3	PTGS1 PTGS2	1.50e-03	10	110	2	PS50292
Domain	-	PTGS1 PTGS2	1.50e-03	10	110	2	1.10.640.10
Domain	Dynamin_GTPase	NUGGC MFN1	3.43e-03	15	110	2	IPR001401
Domain	Dynamin_SF	NUGGC MFN1	3.43e-03	15	110	2	IPR022812
Domain	Dynamin_N	NUGGC MFN1	3.43e-03	15	110	2	PF00350
Domain	-	SMG1 TRRAP	3.91e-03	16	110	2	1.10.1070.11
Domain	PI3Kc	SMG1 TRRAP	3.91e-03	16	110	2	SM00146
Domain	PI3_PI4_kinase	SMG1 TRRAP	4.95e-03	18	110	2	PF00454
Domain	PI3_4_KINASE_1	SMG1 TRRAP	4.95e-03	18	110	2	PS00915
Domain	PI3_4_KINASE_2	SMG1 TRRAP	4.95e-03	18	110	2	PS00916
Domain	PI3/4_kinase_cat_dom	SMG1 TRRAP	4.95e-03	18	110	2	IPR000403
Domain	PI3_4_KINASE_3	SMG1 TRRAP	4.95e-03	18	110	2	PS50290
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	GTPBP4 PDGFRA CHD8 ZFX ZFY PBRM1 ANP32E CHD6 MGA DDX24	2.60e-12	109	112	10	33554859
Pubmed	Human transcription factor protein interaction networks.	CYLD GTPBP4 SMG1 ESS2 CASP14 KRT74 BAZ1B GON4L CHD8 CHD3 POGZ TRRAP FHAD1 PBRM1 SNW1 TRIM9 NAT10 BRD9 SMARCA2 CHD6 SPOP CACYBP MGA DDX24	2.36e-11	1429	112	24	35140242
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CUL1 GTPBP4 SETX NAA15 CASP14 PLEKHG4 BAZ1B MCM4 CHD8 FAM98A POGZ TRRAP NCAPG2 SNW1 LMNB1 NAT10 DIAPH1 SF3A3 SMARCA2 PPP1R37 PRKCA MGA DDX24	5.19e-11	1353	112	23	29467282
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	GTPBP4 BAZ1B CHD8 CHD3 POGZ TRRAP ZFX ZFY ZNF711 PBRM1 NAT10 BRD9 SMARCA2 TNNC1 MGA	2.00e-10	533	112	15	30554943
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	GTPBP4 SETX ESS2 BAZ1B CHD8 CHD3 POGZ TRRAP ZNF711 PBRM1 NAT10 BRD9 CHD6 MGA DDX24	1.21e-09	608	112	15	36089195
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	GIPC1 CUL1 GTPBP4 RBM26 BAZ1B MCM4 CHD8 CHD3 TRRAP PBRM1 SNW1 NAT10 BRD9 DIAPH1 SMARCA2 ANP32E METTL16 CACYBP	4.30e-09	1014	112	18	32416067
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SETX RBM26 BAZ1B MCM4 CHD8 CHD3 FAM98A POGZ ZNF711 SNW1 LMNB1 NAT10 BRD9 EIF5 SF3A3 MGA DDX24	1.15e-08	954	112	17	36373674
Pubmed	Characterization of the ZFX family of transcription factors that bind downstream of the start site of CpG island promoters.	ZFX ZFY ZNF711	3.25e-08	3	112	3	32406922
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	GTPBP4 ESS2 PARP2 BAZ1B MCM4 CHD8 FAM98A PBRM1 SNW1 LMNB1 NAT10 BRD9 DIAPH1 SF3A3 SMARCA2 ANP32E CHD6 CACYBP DDX24	4.28e-08	1318	112	19	30463901
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	BAZ1B CHD3 POGZ PBRM1 SNW1 SMARCA2 DDX24	4.56e-08	103	112	7	32744500
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	BAZ1B CHD8 CHD3 TRRAP PBRM1 BRD9 SMARCA2 CHD6	4.61e-08	157	112	8	30186101
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	PARP2 RBM26 GON4L MCM4 CHD8 CHD3 POGZ TRRAP PBRM1 ANP32E DDX24	6.48e-08	394	112	11	27248496
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	GTPBP4 KRT16 CASP14 BAZ1B CHD3 FAM98A PBRM1 SNW1 LMNB1 NAT10 SF3A3 SMARCA2 DDX24	8.28e-08	605	112	13	28977666
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GIPC1 CYLD GTPBP4 STRN3 RIPK2 CHD8 MAGI2 PBRM1 SNW1 LMNB1 KCNJ4 NAT10 DIAPH1 PRKCA MGA EPB41L1	8.38e-08	963	112	16	28671696
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CUL1 SETX NAA15 ESS2 RBM26 MCM4 CHD8 CHD3 POGZ TRRAP NCAPG2 SNW1 BRD9 EIF5 SMARCA2 ANP32E CACYBP	9.30e-08	1103	112	17	34189442
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD GTPBP4 BAZ1B CHD8 CHD3 POGZ PRDM5 TRRAP ZNF711 PBRM1 NAT10 BRD9 DIAPH1 SMARCA2 SPOP MGA DDX24	1.10e-07	1116	112	17	31753913
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	CUL1 SETX ESS2 PLEKHG4 PARP2 RBM26 MCM4 POGZ TRRAP FBXW8 UBA7 SF3A3 TMF1 MGA DDX24	1.13e-07	857	112	15	25609649
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	GTPBP4 ESS2 MCM4 CHD8 POGZ TRRAP SNW1 NAT10 MGA DDX24	1.59e-07	339	112	10	30415952
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GTPBP4 NAA15 BAZ1B MCM4 CHD8 POGZ TRRAP ME2 PBRM1 SNW1 NAT10 SMARCA2 DDX24	1.99e-07	653	112	13	22586326
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	GTPBP4 BAZ1B CHD8 TRRAP PBRM1 LMNB1 NAT10 DDX24	2.44e-07	195	112	8	19454010
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	RBM26 MCM4 CHD8 CHD3 POGZ PBRM1 SNW1 NAT10 SF3A3	2.53e-07	271	112	9	32433965
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	GIPC1 STRN3 SETX GIPC2 PARP2 RBM26 BAZ1B GON4L CHD8 FAM98A TRRAP PBRM1 FGD4 BRD9 EIF5 SMARCA2 TMF1 CHD6 EPB41L1	3.06e-07	1497	112	19	31527615
Pubmed	A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia.	PTGS1 PTGS2 PLA2G4C	3.24e-07	5	112	3	16181776
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	RBM26 BAZ1B CHD8 CHD3 ZNF711 SNW1 NAT10 ANP32E MGA	3.64e-07	283	112	9	30585729
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	STRN3 SETX MAN1C1 RBM26 MCM4 CHD8 PBRM1 TMF1 PRKCA DDX24 EPB41L1	7.33e-07	503	112	11	16964243
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CUL1 GTPBP4 SETX PARP2 BAZ1B CHD3 POGZ TRRAP ZFX PBRM1 SNW1 LMNB1 NAT10 SF3A3 CHD6 MGA DDX24	8.64e-07	1294	112	17	30804502
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	GTPBP4 SMG1 CHD8 CHD3 TRRAP SNW1 SF3A3 SMARCA2 MGA DDX24	9.03e-07	410	112	10	26949251
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GTPBP4 KRT16 CASP14 BAZ1B MCM4 CHD3 TRRAP FBXW8 PBRM1 SNW1 LMNB1 NAT10 SF3A3 PRKCA MGA	1.07e-06	1024	112	15	24711643
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SWAP70 RBM26 BAZ1B CHD8 POGZ TRRAP SNW1 LMNB1 NAT10 CACYBP MGA	1.71e-06	549	112	11	38280479
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GTPBP4 STRN3 NAA15 RBM26 BAZ1B MCM4 CHD3 ME2 SNW1 TRIM9 NAT10 EIF5 ANP32E CACYBP	1.93e-06	934	112	14	33916271
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	GTPBP4 PARP2 BAZ1B MCM4 ZNF711 NAT10 CACYBP MGA DDX24	2.06e-06	349	112	9	25665578
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	ESS2 BAZ1B CHD8 ACE LMNB1 EIF5	2.77e-06	121	112	6	22412018
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CUL1 GTPBP4 RBM26 BAZ1B MCM4 POGZ ME2 PBRM1 SNW1 LMNB1 NAT10 EIF5 DIAPH1 SF3A3 ANP32E CACYBP DDX24	3.18e-06	1425	112	17	30948266
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	GTPBP4 ESS2 PDGFRA PARP2 RBM26 BAZ1B MCM4 PTGS2 SNW1 LMNB1 NAT10 SF3A3 ANP32E DDX24	3.74e-06	989	112	14	36424410
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ESS2 CHD8 TRRAP SNW1 NAT10 MGA	5.00e-06	134	112	6	25452129
Pubmed	Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.	CUL1 TRRAP USH2A	5.26e-06	11	112	3	24349473
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	STRN3 MCM4 PBRM1 BRD9 EIF5 CACYBP MGA	6.54e-06	215	112	7	35973513
Pubmed	Common genetic variation, residential proximity to traffic exposure, and left ventricular mass: the multi-ethnic study of atherosclerosis.	ACE PTGS1 PTGS2	7.00e-06	12	112	3	20308035
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	GTPBP4 KRT16 CASP14 KRT74 BAZ1B CHD3 SNW1 LMNB1 NAT10 SF3A3 ANP32E	7.47e-06	641	112	11	36057605
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	GTPBP4 ESS2 RBM26 POGZ NCAPG2 SNW1 MGA	8.06e-06	222	112	7	37071664
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	CUL1 GTPBP4 NAA15 RBM26 BAZ1B MCM4 CHD3 MFN1 SNW1 NAT10 SF3A3	8.88e-06	653	112	11	33742100
Pubmed	Functional interaction of megalin with the megalinbinding protein (MegBP), a novel tetratrico peptide repeat-containing adaptor molecule.	GIPC1 SNW1 PICK1	9.08e-06	13	112	3	12508107
Pubmed	Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.	RAG1 PTGS1 PTGS2	9.08e-06	13	112	3	18480244
Pubmed	Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH.	PTGS1 PTGS2	1.03e-05	2	112	2	12411530
Pubmed	Expression of the two isoforms of prostaglandin endoperoxide synthase (PGHS-1 and PGHS-2) during adipose cell differentiation.	PTGS1 PTGS2	1.03e-05	2	112	2	9256365
Pubmed	An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes.	PTGS1 PTGS2	1.03e-05	2	112	2	12665651
Pubmed	The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.	PTGS1 PTGS2	1.03e-05	2	112	2	19887674
Pubmed	Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.	PTGS1 PTGS2	1.03e-05	2	112	2	10944235
Pubmed	Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses.	PTGS1 PTGS2	1.03e-05	2	112	2	16081878
Pubmed	Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide.	PTGS1 PTGS2	1.03e-05	2	112	2	11694451
Pubmed	Effects of Cyclooxygenase on the Urothelium of the Urinary Bladder of Mice Exposed to Pelvic Radiation.	PTGS1 PTGS2	1.03e-05	2	112	2	27386631
Pubmed	Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein.	PTGS1 PTGS2	1.03e-05	2	112	2	15263079
Pubmed	Genetic model of selective COX2 inhibition reveals novel heterodimer signaling.	PTGS1 PTGS2	1.03e-05	2	112	2	16732282
Pubmed	Disruption of cyclooxygenase genes in mice.	PTGS1 PTGS2	1.03e-05	2	112	2	8994299
Pubmed	The COX-2 pathway is essential during early stages of skeletal muscle regeneration.	PTGS1 PTGS2	1.03e-05	2	112	2	15084473
Pubmed	Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms.	PTGS1 PTGS2	1.03e-05	2	112	2	17631383
Pubmed	Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene.	ZFX ZFY	1.03e-05	2	112	2	1691708
Pubmed	Mucosal expression of cyclooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa.	PTGS1 PTGS2	1.03e-05	2	112	2	15720413
Pubmed	Suppression of adipogenesis program in cultured preadipocytes transfected stably with cyclooxygenase isoforms.	PTGS1 PTGS2	1.03e-05	2	112	2	19416639
Pubmed	The structure of the Zfx gene on the mouse X chromosome.	ZFX ZFY	1.03e-05	2	112	2	8188262
Pubmed	Polymorphonuclear myeloid-derived suppressor cells attenuate allergic airway inflammation by negatively regulating group 2 innate lymphoid cells.	RAG1 PTGS1	1.03e-05	2	112	2	30575026
Pubmed	Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis.	PTGS1 PTGS2	1.03e-05	2	112	2	15504548
Pubmed	Role of Asn-382 and Thr-383 in activation and inactivation of human prostaglandin H synthase cyclooxygenase catalysis.	PTGS1 PTGS2	1.03e-05	2	112	2	14625295
Pubmed	Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells.	PTGS1 PTGS2	1.03e-05	2	112	2	9463402
Pubmed	Expression and function of COX isoforms in renal medulla: evidence for regulation of salt sensitivity and blood pressure.	PTGS1 PTGS2	1.03e-05	2	112	2	16189289
Pubmed	Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours.	PTGS1 PTGS2	1.03e-05	2	112	2	12519124
Pubmed	Mapping the human ZFX locus to Xp21.3 by in situ hybridization.	ZFX ZFY	1.03e-05	2	112	2	2497060
Pubmed	Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.	PTGS1 PTGS2	1.03e-05	2	112	2	11920472
Pubmed	Neurosensory perception of environmental cues modulates sperm motility critical for fertilization.	PTGS1 PTGS2	1.03e-05	2	112	2	24833393
Pubmed	Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY.	ZFX ZFY	1.03e-05	2	112	2	2041734
Pubmed	Role of cyclooxygenase-1 and -2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas.	PTGS1 PTGS2	1.03e-05	2	112	2	26444418
Pubmed	Gene expression, X-inactivation, and methylation during spermatogenesis: the case of Zfa, Zfx, and Zfy in mice.	ZFX ZFY	1.03e-05	2	112	2	8318216
Pubmed	Lung inflammation caused by adenosine-5'-triphosphate is mediated via Ca2+/PKCs-dependent COX-2/PGE2 induction.	PTGS2 PRKCA	1.03e-05	2	112	2	23680674
Pubmed	Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells.	PTGS1 PTGS2	1.03e-05	2	112	2	10548515
Pubmed	Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice.	PTGS1 PTGS2	1.03e-05	2	112	2	15831902
Pubmed	LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression.	PTGS1 PTGS2	1.03e-05	2	112	2	23874970
Pubmed	Binding of elements of protein kinase C-alpha regulatory domain to lamin B1.	LMNB1 PRKCA	1.03e-05	2	112	2	12135703
Pubmed	Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis.	PTGS1 PTGS2	1.03e-05	2	112	2	10668482
Pubmed	Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation.	PTGS1 PTGS2	1.03e-05	2	112	2	19885646
Pubmed	Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.	PTGS1 PTGS2	1.03e-05	2	112	2	18355636
Pubmed	Cyclooxygenase 1 is required for pH control at the mouse gastric surface.	PTGS1 PTGS2	1.03e-05	2	112	2	15542509
Pubmed	Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation.	PTGS1 PTGS2	1.03e-05	2	112	2	17681165
Pubmed	Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.	PTGS1 PTGS2	1.03e-05	2	112	2	11705824
Pubmed	Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes.	PTGS1 PTGS2	1.03e-05	2	112	2	14988266
Pubmed	Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.	PTGS1 PTGS2	1.03e-05	2	112	2	10727451
Pubmed	[Expression of Zfx in mouse testicular spermatogenic cells].	ZFX ZFY	1.03e-05	2	112	2	38602753
Pubmed	COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma.	PTGS1 PTGS2	1.03e-05	2	112	2	18753249
Pubmed	Seminal cyclooxygenase relationship with oxidative stress in infertile oligoasthenoteratozoospermic men with varicocele.	PTGS1 PTGS2	1.03e-05	2	112	2	25906828
Pubmed	Immunohistochemical and ultrastructural localization of prostaglandin H synthase in the preimplantation mouse embryo.	PTGS1 PTGS2	1.03e-05	2	112	2	8882280
Pubmed	Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice.	PTGS1 PTGS2	1.03e-05	2	112	2	16815697
Pubmed	Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues.	PTGS1 PTGS2	1.03e-05	2	112	2	19769727
Pubmed	Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response.	PTGS1 PTGS2	1.03e-05	2	112	2	27845343
Pubmed	Ocular prostaglandin production and morphology in mice lacking a single isoform of cyclooxygenase.	PTGS1 PTGS2	1.03e-05	2	112	2	19767186
Pubmed	Cyclooxygenase knockout mice: models for elucidating isoform-specific functions.	PTGS1 PTGS2	1.03e-05	2	112	2	10487525
Pubmed	Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.	PTGS1 PTGS2	1.03e-05	2	112	2	20720307
Pubmed	Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?	PTGS1 PTGS2	1.03e-05	2	112	2	18657230
Pubmed	Cyclo-oxygenase 2 function is essential for bone fracture healing.	PTGS1 PTGS2	1.03e-05	2	112	2	12054171
Pubmed	Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation.	PTGS1 PTGS2	1.03e-05	2	112	2	15190260
Pubmed	Distinct expression of cyclooxygenase-1 and -2 in the human thymus.	PTGS1 PTGS2	1.03e-05	2	112	2	11981837
Pubmed	Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone.	PTGS1 PTGS2	1.03e-05	2	112	2	18838483
Interaction	TWIST1 interactions	GTPBP4 PDGFRA CHD8 CHD3 ZFX PBRM1 ANP32E CHD6 SPOP MGA DDX24	2.30e-09	170	110	11	int:TWIST1
Interaction	CENPA interactions	GTPBP4 PARP2 BAZ1B MCM4 CHD3 TRRAP ZNF711 PBRM1 LMNB1 BRD9 DIAPH1 SMARCA2 CHD6 DDX24	1.83e-08	377	110	14	int:CENPA
Interaction	KPNA1 interactions	CUL1 GTPBP4 RAG1 BAZ1B CHD8 CHD3 TRRAP PBRM1 SNW1 LMNB1 SMARCA2 ANP32E SPOP	6.31e-08	351	110	13	int:KPNA1
Interaction	H3C1 interactions	GIPC1 GTPBP4 RAG1 PARP2 BAZ1B MCM4 CHD8 CHD3 POGZ TRRAP ZNF711 PBRM1 SNW1 NAT10 SMARCA2 ANP32E PRKCA MGA DDX24	3.88e-07	901	110	19	int:H3C1
Interaction	POLR1E interactions	CUL1 GTPBP4 CHD8 POGZ TRRAP ZNF711 PBRM1 NAT10 ANP32E PRKCA CHD6 MGA	4.77e-07	350	110	12	int:POLR1E
Interaction	H3C3 interactions	GTPBP4 SETX ESS2 BAZ1B CHD8 CHD3 POGZ TRRAP PBRM1 NAT10 BRD9 CHD6 MGA DDX24	5.16e-07	495	110	14	int:H3C3
Interaction	H2BC8 interactions	ESS2 PARP2 BAZ1B GON4L CHD8 CHD3 POGZ TRRAP ZNF711 PBRM1 SNW1 NAT10 ANP32E CHD6 MGA	5.57e-07	576	110	15	int:H2BC8
Interaction	BRD2 interactions	GTPBP4 BAZ1B CHD8 CHD3 POGZ ZNF711 PBRM1 NAT10 BRD9 SMARCA2 SPOP DDX24 EPB41L1	6.27e-07	429	110	13	int:BRD2
Interaction	LHX1 interactions	GTPBP4 POGZ TRRAP PBRM1 SMARCA2 MGA DDX24	1.53e-06	103	110	7	int:LHX1
Interaction	BRD3 interactions	GTPBP4 BAZ1B CHD8 POGZ ZFY ZNF711 PBRM1 NAT10 BRD9 SMARCA2 SPOP TNNC1 MGA	3.00e-06	494	110	13	int:BRD3
Interaction	PRPF31 interactions	CYLD STRN3 PLEKHG4 CHD8 CHD3 RHOBTB2 SF3A3 SLAIN1 CACYBP MGA PICK1	6.41e-06	374	110	11	int:PRPF31
Interaction	KRT84 interactions	CYLD KRT16 KRT74 CHD3 DDX24	6.96e-06	49	110	5	int:KRT84
Interaction	SMC5 interactions	ZNF597 SETX RBM26 BAZ1B MCM4 CHD8 CHD3 FAM98A POGZ ZNF711 SNW1 LMNB1 NAT10 BRD9 EIF5 SF3A3 MGA DDX24	7.54e-06	1000	110	18	int:SMC5
Interaction	PARP1 interactions	CYLD CUL1 GTPBP4 NAA15 SWAP70 PARP2 BAZ1B MCM4 CHD3 FAM98A POGZ TRRAP ZNF711 PBRM1 LMNB1 NAT10 SMARCA2 ANP32E CHD6 CACYBP MGA	7.70e-06	1316	110	21	int:PARP1
Interaction	KLF9 interactions	GTPBP4 BAZ1B GON4L PBRM1 MGA DDX24	1.19e-05	93	110	6	int:KLF9
Interaction	H2BC3 interactions	CYLD PARP2 GON4L MCM4 CHD8 CHD3 POGZ TRRAP PBRM1 ANP32E DDX24	1.38e-05	406	110	11	int:H2BC3
Interaction	POLR1G interactions	CUL1 GTPBP4 NAA15 CHD8 POGZ TRRAP NCAPG2 PBRM1 NAT10 ANP32E MGA DDX24	1.49e-05	489	110	12	int:POLR1G
Interaction	CHD3 interactions	GTPBP4 SETX KRT16 CASP14 BAZ1B CHD3 FAM98A PBRM1 SNW1 LMNB1 NAT10 SMARCA2 CHD6 SPOP DDX24	1.55e-05	757	110	15	int:CHD3
Interaction	BCAS2 interactions	CYLD CUL1 ESS2 CHD3 TRRAP LINS1 SNW1 LMNB1 SLAIN1	1.74e-05	270	110	9	int:BCAS2
Interaction	H2BC10 interactions	PARP2 GON4L MCM4 TRRAP ANP32E	2.06e-05	61	110	5	int:H2BC10
Interaction	KRT80 interactions	CYLD KRT16 CHD3 SPOP DDX24	2.61e-05	64	110	5	int:KRT80
Interaction	KPNA2 interactions	CUL1 RAG1 MCM4 CHD8 CHD3 TRRAP FBXW8 PBRM1 SNW1 LMNB1 SMARCA2 RGL2	2.67e-05	519	110	12	int:KPNA2
Interaction	ZNF330 interactions	GTPBP4 ESS2 BAZ1B CHD3 ZNF711 PBRM1 LMNB1 NAT10 ANP32E DDX24 PICK1	3.29e-05	446	110	11	int:ZNF330
Interaction	DNAJC9 interactions	CUL1 GTPBP4 BAZ1B MCM4 FBXW8 FGD4 NAT10 ANP32E DDX24	3.58e-05	296	110	9	int:DNAJC9
Interaction	NUP43 interactions	SETX RBM26 GON4L CHD8 CHD3 POGZ ZFX ZNF711 PBRM1 LMNB1 CHD6 MGA DDX24	3.65e-05	625	110	13	int:NUP43
Interaction	CEBPA interactions	CUL1 SETX NAA15 ESS2 RBM26 MCM4 CHD8 CHD3 POGZ TRRAP NCAPG2 SNW1 LMNB1 NAT10 BRD9 EIF5 SMARCA2 ANP32E CACYBP	4.11e-05	1245	110	19	int:CEBPA
Interaction	COIL interactions	GTPBP4 ESS2 PLEKHG4 CHD8 CHD3 POGZ ZNF711 PBRM1 CHD6 MGA DDX24 PICK1	4.86e-05	552	110	12	int:COIL
Interaction	H3-3A interactions	ESS2 PDGFRA PARP2 BAZ1B CHD8 CHD3 POGZ TRRAP ZNF711 PBRM1 NAT10 BRD9 EIF5 MGA	5.75e-05	749	110	14	int:H3-3A
Interaction	DDX23 interactions	GTPBP4 RBM26 MCM4 CHD3 TRRAP SNW1 LMNB1 NAT10 SF3A3 ANP32E DDX24	6.38e-05	480	110	11	int:DDX23
Interaction	NANOG interactions	GTPBP4 KRT16 POGZ TRRAP FBXW8 PBRM1 LMNB1 SMARCA2 SPOP MGA DDX24	6.50e-05	481	110	11	int:NANOG
Interaction	LHX2 interactions	GTPBP4 BAZ1B POGZ PBRM1 SMARCA2 MGA DDX24	6.57e-05	183	110	7	int:LHX2
Interaction	ZNF692 interactions	GTPBP4 ASTE1 MGA DDX24	8.02e-05	42	110	4	int:ZNF692
Interaction	NPM1 interactions	CYLD CUL1 GTPBP4 NAA15 SWAP70 PARP2 BAZ1B CHD8 CHD3 FAM98A TRRAP PBRM1 LMNB1 NAT10 PRKCA RPGR CACYBP DDX24	8.49e-05	1201	110	18	int:NPM1
Interaction	KRT5 interactions	CYLD CUL1 KRT16 KRT74 CHD3 SPOP DDX24	9.18e-05	193	110	7	int:KRT5
Interaction	KLF12 interactions	GTPBP4 CHD3 TRRAP PBRM1 CHD6 MGA DDX24	9.48e-05	194	110	7	int:KLF12
Interaction	WDR5 interactions	CYLD CUL1 GTPBP4 GIPC2 NAA15 CHD8 CHD3 TRRAP SNW1 LMNB1 NAT10 BRD9 EIF5 DIAPH1 SMARCA2 METTL16 MGA	9.54e-05	1101	110	17	int:WDR5
Interaction	KLF5 interactions	GTPBP4 KRT74 PBRM1 SMARCA2 PRKCA MGA DDX24	9.79e-05	195	110	7	int:KLF5
Interaction	H2AC4 interactions	CUL1 PARP2 RBM26 GON4L MCM4 CHD8 CHD3 POGZ PBRM1 ANP32E DDX24	1.02e-04	506	110	11	int:H2AC4
Interaction	TOP1 interactions	CUL1 PDGFRA BAZ1B MCM4 CHD3 POGZ PBRM1 SNW1 RHOBTB2 NAT10 DIAPH1 SF3A3 DDX24	1.08e-04	696	110	13	int:TOP1
Interaction	UHRF2 interactions	BAZ1B CHD8 CHD3 NCAPG2 PBRM1 NAT10 MGA	1.15e-04	200	110	7	int:UHRF2
Interaction	MYO1B interactions	CYLD CUL1 PDGFRA CHD3 POGZ SPOP TNNC1 DDX24	1.27e-04	273	110	8	int:MYO1B
Interaction	KPNA5 interactions	IL32 CHD8 LMNB1 ANP32E SPOP	1.27e-04	89	110	5	int:KPNA5
Interaction	XRCC6 interactions	NAA15 SWAP70 PARP2 RBM26 BAZ1B CHD8 CHD3 TRRAP ZNF711 SNW1 NAT10 DIAPH1 ANP32E CACYBP MGA	1.56e-04	928	110	15	int:XRCC6
Interaction	CHD4 interactions	GTPBP4 KRT16 CASP14 BAZ1B MCM4 CHD3 POGZ PBRM1 SNW1 LMNB1 NAT10 EIF5 SF3A3 SMARCA2 DDX24	1.75e-04	938	110	15	int:CHD4
Interaction	PAX6 interactions	RBM26 CHD3 POGZ PBRM1 DIAPH1 SMARCA2 CHD6 MGA PICK1	1.80e-04	366	110	9	int:PAX6
Interaction	SNRNP40 interactions	SETX ESS2 GON4L MCM4 CHD3 POGZ FBXW8 SNW1 LMNB1 SF3A3 MGA DDX24	1.87e-04	637	110	12	int:SNRNP40
Interaction	NR2C2 interactions	GTPBP4 ESS2 PARP2 BAZ1B MCM4 CHD8 FAM98A PBRM1 SNW1 LMNB1 NAT10 BRD9 DIAPH1 SF3A3 SMARCA2 ANP32E CHD6 CACYBP DDX24	1.99e-04	1403	110	19	int:NR2C2
Interaction	H2AZ1 interactions	PARP2 BAZ1B CHD8 POGZ TRRAP PBRM1 LMNB1 RHOBTB2 ANP32E	2.00e-04	371	110	9	int:H2AZ1
Interaction	SUZ12 interactions	GTPBP4 SETX ARMC12 MCM4 CHD8 CHD3 TRRAP PBRM1 SNW1 NAT10 SF3A3 SMARCA2	2.07e-04	644	110	12	int:SUZ12
Interaction	SIRT7 interactions	GTPBP4 NAA15 BAZ1B MCM4 CHD8 POGZ TRRAP ME2 PBRM1 SNW1 NAT10 SMARCA2 DDX24	2.09e-04	744	110	13	int:SIRT7
Interaction	MBD3 interactions	CUL1 KRT16 BAZ1B MCM4 CHD3 TRRAP SMARCA2 PICK1	2.16e-04	295	110	8	int:MBD3
Interaction	CWC27 interactions	TRRAP SNW1 LMNB1 SF3A3 EPB41L1	2.20e-04	100	110	5	int:CWC27
Interaction	KRT6A interactions	CYLD CUL1 KRT16 KRT74 CHD3 POGZ	2.47e-04	160	110	6	int:KRT6A
Interaction	KLF3 interactions	CHD3 POGZ ME2 PBRM1 SMARCA2 CHD6 MGA	2.57e-04	228	110	7	int:KLF3
Interaction	SP7 interactions	CUL1 ESS2 CHD3 POGZ PBRM1 SMARCA2 MGA DDX24	2.65e-04	304	110	8	int:SP7
Interaction	NAA40 interactions	GTPBP4 STRN3 NAA15 PARP2 RBM26 BAZ1B MCM4 CHD3 ME2 SNW1 TRIM9 NAT10 EIF5 ANP32E CACYBP	2.75e-04	978	110	15	int:NAA40
Interaction	H2AC17 interactions	CUL1 GTPBP4 PARP2 BAZ1B GON4L NAT10 DDX24	2.85e-04	232	110	7	int:H2AC17
Interaction	GFI1 interactions	CUL1 PRDM5 PICK1	2.95e-04	24	110	3	int:GFI1
Interaction	LHX4 interactions	GTPBP4 POGZ TRRAP PBRM1 SMARCA2 MGA	3.01e-04	166	110	6	int:LHX4
Interaction	RUVBL1 interactions	CUL1 SMG1 PLEKHG4 CHD8 CHD3 TRRAP SNW1 SMARCA2 ANP32E SPOP MGA	3.08e-04	575	110	11	int:RUVBL1
Interaction	ZCCHC10 interactions	PLEKHG4 SNW1 BRD9 SMARCA2 CHD6 DDX24 EPB41L1	3.16e-04	236	110	7	int:ZCCHC10
Interaction	CARD8 interactions	SETX CHD8 TRRAP MGA	3.24e-04	60	110	4	int:CARD8
Interaction	ADARB1 interactions	GTPBP4 RBM26 MCM4 CHD8 CHD3 PBRM1 SNW1 NAT10 SF3A3 DDX24	3.47e-04	489	110	10	int:ADARB1
Interaction	H2BC6 interactions	PARP2 GON4L TRRAP ANP32E	3.67e-04	62	110	4	int:H2BC6
Interaction	FLG2 interactions	CYLD CASP14 ARMC12 CHD3 DDX24	3.73e-04	112	110	5	int:FLG2
Interaction	PFKFB1 interactions	PLEKHG4 PFKFB4 PRKCA	3.75e-04	26	110	3	int:PFKFB1
Interaction	FBXL7 interactions	CUL1 PFKFB4 TRRAP	3.75e-04	26	110	3	int:FBXL7
Interaction	PSMB6 interactions	CYLD CUL1 NAA15 TRRAP FBXW8 PRKCA DDX24	3.77e-04	243	110	7	int:PSMB6
Interaction	SMC3 interactions	MCM4 CHD3 TRRAP PBRM1 SNW1 NAT10 SMARCA2 RPGR MGA	4.01e-04	408	110	9	int:SMC3
Interaction	ELF4 interactions	POGZ TRRAP PBRM1 SMARCA2 MGA	4.21e-04	115	110	5	int:ELF4
Interaction	ASF1A interactions	CUL1 ESS2 MCM4 CHD8 POGZ CHD6 MGA	4.36e-04	249	110	7	int:ASF1A
Interaction	H2BC1 interactions	PARP2 GON4L MCM4 TRRAP SMARCA2 ANP32E	4.37e-04	178	110	6	int:H2BC1
Interaction	MEN1 interactions	CUL1 GTPBP4 RBM26 BAZ1B CHD8 CHD3 FAM98A POGZ TRRAP ZFY PBRM1 SNW1 NAT10 SF3A3 DDX24	4.70e-04	1029	110	15	int:MEN1
Interaction	HNRNPU interactions	CYLD CUL1 GTPBP4 ARMC12 BAZ1B MCM4 CHD3 SNW1 LMNB1 NAT10 SF3A3 TMF1 SPOP DDX24 SERTAD1	4.99e-04	1035	110	15	int:HNRNPU
Interaction	H2BC26 interactions	CYLD PARP2 GON4L TRRAP ANP32E SPOP	5.07e-04	183	110	6	int:H2BC26
Interaction	DDIT3 interactions	GIPC1 CUL1 PBRM1 SMARCA2 SPOP	5.12e-04	120	110	5	int:DDIT3
Interaction	H1-0 interactions	CYLD PARP2 BAZ1B MCM4 CHD8 POGZ PBRM1	5.15e-04	256	110	7	int:H1-0
Interaction	DSP interactions	CYLD KRT16 CASP14 CHD3 TRRAP FBXW8 SNW1 PRKCA DDX24	5.20e-04	423	110	9	int:DSP
Interaction	BTG2 interactions	CUL1 PRKCA PICK1	5.21e-04	29	110	3	int:BTG2
Interaction	PTEN interactions	CUL1 SETX PDGFRA MAGI2 PBRM1 LMNB1 EIF5 ANP32E SPOP METTL16 CACYBP DDX24 EPB41L1 PICK1	5.31e-04	929	110	14	int:PTEN
Interaction	KLF16 interactions	GTPBP4 ESS2 BAZ1B GON4L POGZ SNW1 NAT10 MGA DDX24	5.38e-04	425	110	9	int:KLF16
Interaction	PTGIS interactions	PTGS1 PTGS2	6.09e-04	7	110	2	int:PTGIS
Interaction	FZR1 interactions	CYLD CUL1 GTPBP4 SMG1 KRT16 CASP14 PDGFRA RBM26 BAZ1B CHD8 FAM98A NAT10 SPOP SHCBP1L CACYBP DDX24	6.15e-04	1172	110	16	int:FZR1
Interaction	TNP2 interactions	PARP2 PBRM1 PRKCA	6.36e-04	31	110	3	int:TNP2
Interaction	NAA20 interactions	NAA15 SWAP70 CACYBP	6.36e-04	31	110	3	int:NAA20
Interaction	ELF1 interactions	POGZ TRRAP PBRM1 SMARCA2 MGA	6.39e-04	126	110	5	int:ELF1
Interaction	RPS14 interactions	CYLD CUL1 GTPBP4 RIPK2 CHD3 NAT10 EIF5 SF3A3 SPOP DDX24	6.40e-04	529	110	10	int:RPS14
Interaction	SIRT6 interactions	GTPBP4 SMG1 PARP2 MCM4 CHD8 CHD3 TRRAP PBRM1 NAT10 SMARCA2 CACYBP	6.45e-04	628	110	11	int:SIRT6
Interaction	PRSS1 interactions	CHD3 PRDM5 TRRAP DDX24	6.85e-04	73	110	4	int:PRSS1
Interaction	ETV3 interactions	GTPBP4 BAZ1B PBRM1 MGA DDX24	6.87e-04	128	110	5	int:ETV3
Interaction	MYOD1 interactions	TRRAP PBRM1 SNW1 SMARCA2 PRKCA MGA	6.88e-04	194	110	6	int:MYOD1
Interaction	CDT1 interactions	CUL1 BAZ1B MCM4 SPOP	7.21e-04	74	110	4	int:CDT1
Interaction	MSH6 interactions	CYLD PARP2 CHD8 CHD3 PBRM1 SNW1 BRD9	7.21e-04	271	110	7	int:MSH6
Interaction	BRD7 interactions	CUL1 GTPBP4 PARP2 FAM98A PBRM1 SNW1 NAT10 BRD9 SMARCA2 ANP32E DDX24	7.25e-04	637	110	11	int:BRD7
Interaction	RPS19 interactions	CYLD CUL1 GTPBP4 SWAP70 BAZ1B CHD3 ZNF711 NAT10 EIF5 SPOP DDX24	7.43e-04	639	110	11	int:RPS19
Interaction	USP7 interactions	ANKRD31 CUL1 GTPBP4 GON4L MCM4 TRRAP PTGS2 IFT43 ZNF711 PBRM1 PLA2G4C LMNB1 NAT10 TMF1 RPGR DDX24 PICK1	7.45e-04	1313	110	17	int:USP7
Interaction	KRT16 interactions	CYLD CUL1 KRT16 KRT74 CHD3 DDX24	7.46e-04	197	110	6	int:KRT16
Interaction	ACTR1A interactions	CYLD CUL1 MCM4 SNW1 LMNB1 SF3A3 CACYBP	7.69e-04	274	110	7	int:ACTR1A
Interaction	HNRNPCL2 interactions	GTPBP4 SETX BAZ1B CHD3 PBRM1 PPP1R37 DDX24	7.69e-04	274	110	7	int:HNRNPCL2
Interaction	PYHIN1 interactions	GTPBP4 PARP2 BAZ1B MCM4 ZNF711 SF3A3 CACYBP MGA	7.79e-04	358	110	8	int:PYHIN1
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SETX NAA15 FHAD1 SMARCA2 TMF1 RPGR SPAG17	6.86e-07	199	111	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	343B-Fibroblasts-Fibroblast-H\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BRINP3 RIPK2 ACE MFN1 EEF2KMT FBXW8	4.65e-06	172	111	6	eb199c279fe8a2551121db37e9556893197d33ff
ToppCell	343B-Fibroblasts-Fibroblast-H-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BRINP3 RIPK2 ACE MFN1 EEF2KMT FBXW8	4.65e-06	172	111	6	709c6b77a7a52b873eefb6caca28a41291d384af
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	FAM185A MFN1 LINS1 CRYM TMF1 SLAIN1	4.97e-06	174	111	6	2274648b80dd74f3c948a779bba3391095964c34
ToppCell	BAL-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	FAM98A NCAPG2 ZFX ZNF711 SLAIN1 CRISPLD1	7.05e-06	185	111	6	e867ed55ab0df018f14bca824da09d36d83e12f9
ToppCell	ASK454-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	RIPK2 PFKFB4 NCAPG2 BTBD3 ZFY RNF103	7.97e-06	189	111	6	316c857dec9383823e09f966bca62d52d933b141
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CYLD SMG1 CHD3 CD84 SMARCA2 DDX24	1.01e-05	197	111	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Platelets-Platelets\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD31 PTGS1 CD84 UBA7 SEC14L5	1.67e-05	127	111	5	29d0b078b9fb151b2689263828a0a2f178196d16
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Platelets\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD31 PTGS1 CD84 UBA7 SEC14L5	1.67e-05	127	111	5	041fb924aa2138a86612e07a9a5759cbbe2446e0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GIPC1 IL32 MCM4 POGZ FHAD1	6.19e-05	167	111	5	3b717d33aaf1ef0869cc4bca8432ba8008875cc5
ToppCell	Adult-Immune-enucleated_erythrocyte-D122\|Adult / Lineage, Cell type, age group and donor	GIPC2 NCAPG2 PTGS1 CRYM TNNC1	6.55e-05	169	111	5	d5624e5b3687bd3f18f3a2b47a94d11eb1fbdb75
ToppCell	droplet-Fat-Mat-18m-Hematologic-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD3 PTGS2 CD84 SLAIN1 ABCC10	7.93e-05	176	111	5	867936a20f73f638055c19c8d88834aa2cc657cf
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPT1B SMARCA2 SHCBP1L CRISPLD1 CDH13	9.05e-05	181	111	5	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIPC2 CHD3 DIAPH1 DDX24 SERTAD1	1.05e-04	187	111	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	(1)_T_CD4_naive\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CYLD IL32 CHD3 LINS1 PRKCA	1.08e-04	188	111	5	b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	B3GALNT1 IL32 ACE PLA2G4C CDH13	1.08e-04	188	111	5	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGS1 PTGS2 CD84 GADL1 SHCBP1L	1.11e-04	189	111	5	aba941ba6ce7702418b3f470bde573d123c4aade
ToppCell	LAM-Endothelial-VasEndo-1\|LAM / Condition, Lineage and Cell class	B3GALNT1 IL32 ACE PLA2G4C CDH13	1.11e-04	189	111	5	454e64b1ee93edebbc1576fbf7c3a6db332fa927
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGS1 PTGS2 CD84 GADL1 SHCBP1L	1.19e-04	192	111	5	690cf19e9b0b2ada80097c63eae827529aa5b6f3
ToppCell	ASK454-Immune-Mast_cell\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SWAP70 PTGS1 PTGS2 CD84 LMNB1	1.19e-04	192	111	5	4ab2524cce70b6a3a3dd31085b421565a7406c56
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYLD IL32 LINS1 PRKCA DDX24	1.19e-04	192	111	5	7ab626a516b07d899175ff12f1c8257688324e4b
ToppCell	COVID-19_Severe-CD4+_Tcm\|World / disease group, cell group and cell class	CYLD IL32 CD84 LINS1 PRKCA	1.19e-04	192	111	5	3352f13a6e706991dcf3ec173587bb6aba36a385
ToppCell	ASK454-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	SWAP70 PTGS1 PTGS2 CD84 LMNB1	1.19e-04	192	111	5	01e6324146ea34785b770231b40f7a18f128f526
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGS1 PTGS2 CD84 GADL1 SHCBP1L	1.19e-04	192	111	5	3d6c4c5847ca1e44fa380403d25af45d5b51ee9b
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGS1 PTGS2 CD84 GADL1 SHCBP1L	1.19e-04	192	111	5	e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTGS1 PTGS2 CD84 GADL1 SHCBP1L	1.19e-04	192	111	5	b5871247a5f3e970fa05b33fff21bef9d2ab5741
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-Aerocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	IL32 ACE BTBD3 PLA2G4C CDH13	1.25e-04	194	111	5	54b7126b83f7482227aeaea065f504b65fa34bfe
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	B3GALNT1 IL32 ACE PLA2G4C CDH13	1.28e-04	195	111	5	e8992c549dad9a88d2b8d01039a8d02a950b29b4
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	CYLD SMG1 PBRM1 SMARCA2 KRBOX5	1.31e-04	196	111	5	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive\|COVID-19_Severe / Disease group, lineage and cell class	CYLD IL32 CHD3 LINS1 PRKCA	1.35e-04	197	111	5	07f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYLD IL32 CHD3 LINS1 PRKCA	1.35e-04	197	111	5	9f0d91bb7aec4f2442259eca1ddf7905f8d40e9b
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYLD IL32 CHD3 LINS1 PRKCA	1.35e-04	197	111	5	258dfe69b5faeaee709422f873b144ca5e4a6452
ToppCell	healthy_donor-Lymphocytic-T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CYLD IL32 CHD3 CD84 PRKCA	1.35e-04	197	111	5	63d0f06e150e7eb800ecb70e97b9d12a01c84e37
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYLD IL32 CHD3 LINS1 PRKCA	1.35e-04	197	111	5	bf80e39cd68fd5bb85c8726d4f82648391de74ad
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CYLD IL32 CHD3 LINS1 PRKCA	1.35e-04	197	111	5	296b27348ca7e9acf746f752cf810e4e5baea76c
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA MCM4 CHD3 SMARCA2 CDH13	1.35e-04	197	111	5	ad6c200a193a15360d17463e18a465ce1b90b8da
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL32 MCM4 NCAPG2 LMNB1 ANP32E	1.38e-04	198	111	5	55ea8c9d2154ded74c7b851735b24c95bae01de4
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL32 MCM4 NCAPG2 LMNB1 ANP32E	1.38e-04	198	111	5	fc7d8b8e710eedd6cfc1e5393f0c23feac283807
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL32 MCM4 NCAPG2 LMNB1 ANP32E	1.38e-04	198	111	5	ddec07c7bc26d35f155537d907b46e2cb5b55b5f
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	4394dcd1809f49e9bada8f5e115d5123356eae3e
ToppCell	remission-T/NK_proliferative\|remission / disease stage, cell group and cell class	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	303a5fc43a48b05b6f2060d99eef4adc36f8d4e3
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	SETX ACE BTBD3 TNNC1 CDH13	1.41e-04	199	111	5	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	c0ea391bb347b99b94b5d7f02612ede938986745
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SETX NAA15 FHAD1 SMARCA2 TMF1	1.41e-04	199	111	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	96af1f289552f38f2dfa181192eb3276f4c7d70b
ToppCell	mild-CD4+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CYLD IL32 CHD3 PRKCA DDX24	1.41e-04	199	111	5	3e4baaf4ee23f257d821194468102c00a8ad2f21
ToppCell	remission-T/NK_proliferative\|World / disease stage, cell group and cell class	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	f305f3a454b7d2170429bad087480ccccca19acd
ToppCell	distal-2-Endothelial-Capillary_Aerocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	B3GALNT1 IL32 ACE PLA2G4C CDH13	1.41e-04	199	111	5	bf70c8bfe932bccac5014e55f82019c5148627e7
ToppCell	ASK452-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	IL32 RIPK2 PTGS2 UBA7 TNNC1	1.41e-04	199	111	5	48cafe44951908d03f3c6f3e185e9cbb86fb5b3b
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease group, lineage and cell class	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	893b78c661c529db07a5fcc3124d9b3d0f270fa5
ToppCell	COVID-19_Convalescent-T/NK_proliferative\|COVID-19_Convalescent / Disease condition and Cell class	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	c608d953b852b67a4e36bd63d45f0deec3eefbd9
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	5b18e18ddbf4bd53aa0d574d23092cb96da7f400
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	6df65f4c2f9a125e0c7c4f597fefc05a97fc8831
ToppCell	severe-Lymphocytic-Prol._cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	IL32 MCM4 NCAPG2 ANP32E CACYBP	1.41e-04	199	111	5	b24315952b6ac6c8d2d3a7bd949a5b5392624d4e
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.41e-04	199	111	5	cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg\|Bac-SEP / Disease, condition lineage and cell class	GTPBP4 IL32 CD84 ZNF711 SLAIN1	1.41e-04	199	111	5	e0b6136e28b813299b7ffbe37f1cf830e60cd7d8
ToppCell	TCGA-Ovary-Primary_Tumor\|TCGA-Ovary / Sample_Type by Project: Shred V9	PDGFRA FAM98A RHOBTB2 EPB41L1	1.44e-04	106	111	4	14f548be39cec604fbdae0382cbf434fa4049840
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma\|TCGA-Ovary / Sample_Type by Project: Shred V9	PDGFRA FAM98A RHOBTB2 EPB41L1	1.44e-04	106	111	4	939b80950d39cdc7149a05fdfb64c8810064cdb1
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma\|TCGA-Ovary / Sample_Type by Project: Shred V9	PDGFRA FAM98A RHOBTB2 EPB41L1	1.44e-04	106	111	4	e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SETX ACE BTBD3 PLA2G4C RGL2	1.44e-04	200	111	5	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX ACE BTBD3 PLA2G4C RGL2	1.44e-04	200	111	5	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	distal-Endothelial-Capillary_Aerocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	B3GALNT1 IL32 ACE PLA2G4C RGL2	1.44e-04	200	111	5	d36236c7703b759309c8347f44900fc4bed377f0
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease, condition lineage and cell class	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.44e-04	200	111	5	00538c4cbab5da00b3a366717d38a3ba5cfe3f65
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SETX ACE BTBD3 PLA2G4C RGL2	1.44e-04	200	111	5	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.44e-04	200	111	5	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MCM4 NCAPG2 LMNB1 ANP32E CACYBP	1.44e-04	200	111	5	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative\|Leuk-UTI / Disease, condition lineage and cell class	MCM4 PRDM5 NCAPG2 LMNB1 ANP32E	1.44e-04	200	111	5	093e97395be23092229521cc55aaaee8befbc149
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	BRINP3 SETX ESS2 PARP2 POGZ SNW1 EIF5 MGA	3.83e-06	187	111	8	7080_DN
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	BAZ1B GON4L PFKFB4 ZFX ZNF711 LINS1 TRIM9 METTL16	5.21e-06	195	111	8	4466_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	B3GALNT1 BRINP3 ASTE1 ZFX LMNB1 BRD9 EIF5	2.10e-05	171	111	7	7407_DN
Drug	Tolmetin	PTGS1 PTGS2	2.36e-05	2	111	2	DB00500
Drug	Piroxicam	PTGS1 PTGS2	2.36e-05	2	111	2	DB00554
Drug	Fenoprofen	PTGS1 PTGS2	2.36e-05	2	111	2	DB00573
Drug	Tenoxicam	PTGS1 PTGS2	2.36e-05	2	111	2	DB00469
Drug	Ketorolac	PTGS1 PTGS2	2.36e-05	2	111	2	DB00465
Drug	Nabumetone	PTGS1 PTGS2	2.36e-05	2	111	2	DB00461
Drug	AC1O5RN5	PTGS1 PTGS2	2.36e-05	2	111	2	CID006439421
Drug	Tiaprofenic acid	PTGS1 PTGS2	2.36e-05	2	111	2	DB01600
Drug	Acetaminophen	PTGS1 PTGS2	2.36e-05	2	111	2	DB00316
Drug	Antrafenine	PTGS1 PTGS2	2.36e-05	2	111	2	DB01419
Drug	Trisalicylate-choline	PTGS1 PTGS2	2.36e-05	2	111	2	DB01401
Drug	Antipyrine	PTGS1 PTGS2	2.36e-05	2	111	2	DB01435
Drug	gamma-Homolinolenic acid	PTGS1 PTGS2	2.36e-05	2	111	2	DB00154
Drug	Salsalate	PTGS1 PTGS2	2.36e-05	2	111	2	DB01399
Drug	Salicylate-sodium	PTGS1 PTGS2	2.36e-05	2	111	2	DB01398
Drug	Magnesium salicylate	PTGS1 PTGS2	2.36e-05	2	111	2	DB01397
Drug	Bismuth Subsalicylate	PTGS1 PTGS2	2.36e-05	2	111	2	DB01294
Drug	Lumiracoxib	PTGS1 PTGS2	2.36e-05	2	111	2	DB01283
Drug	2-methoxybenzoic acid	PTGS1 PTGS2	2.36e-05	2	111	2	ctd:C081914
Drug	Oxaprozin	PTGS1 PTGS2	2.36e-05	2	111	2	DB00991
Drug	Bromfenac	PTGS1 PTGS2	2.36e-05	2	111	2	DB00963
Drug	Suprofen	PTGS1 PTGS2	2.36e-05	2	111	2	DB00870
Drug	Diflunisal	PTGS1 PTGS2	2.36e-05	2	111	2	DB00861
Drug	Carprofen	PTGS1 PTGS2	2.36e-05	2	111	2	DB00821
Drug	Meloxicam	PTGS1 PTGS2	2.36e-05	2	111	2	DB00814
Drug	Naproxen	PTGS1 PTGS2	2.36e-05	2	111	2	DB00788
Drug	Mefenamic acid	PTGS1 PTGS2	2.36e-05	2	111	2	DB00784
Drug	Flurbiprofen	PTGS1 PTGS2	2.36e-05	2	111	2	DB00712
Drug	MDL 035	PTGS1 PTGS2	2.36e-05	2	111	2	CID000053454
Drug	tricin	PTGS1 PTGS2	2.36e-05	2	111	2	ctd:C017769
Drug	Lornoxicam	PTGS1 PTGS2	2.36e-05	2	111	2	DB06725
Drug	N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide	PTGS1 PTGS2	2.36e-05	2	111	2	ctd:C468797
Drug	Ibuprofen	PTGS1 PTGS2	2.36e-05	2	111	2	DB01050
Drug	Ketoprofen	PTGS1 PTGS2	2.36e-05	2	111	2	DB01009
Drug	SC 299	PTGS1 PTGS2	2.36e-05	2	111	2	ctd:C409370
Drug	flosulide	PTGS1 PTGS2	2.36e-05	2	111	2	ctd:C059178
Drug	cimicoxib	PTGS1 PTGS2	2.36e-05	2	111	2	CID000213053
Drug	Maleimides	PTGS1 PTGS2	2.36e-05	2	111	2	ctd:D008301
Drug	Nepafenac	PTGS1 PTGS2	2.36e-05	2	111	2	DB06802
Drug	ergolide	PTGS1 PTGS2 PRKCA	2.40e-05	12	111	3	CID000185786
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CUL1 GTPBP4 PARP2 CPT1B ZFX LMNB1 SPOP	2.44e-05	175	111	7	4072_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	B3GALNT1 CUL1 BRINP3 EFCAB2 TRRAP LMNB1 EIF5	2.62e-05	177	111	7	6972_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	B3GALNT1 CUL1 PARP2 TRRAP ZFX LMNB1 SPOP	2.72e-05	178	111	7	7245_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CUL1 PARP2 MCM4 CHD3 ZFX LMNB1 SPOP	2.82e-05	179	111	7	2105_DN
Drug	2-cresol	PTGS1 PTGS2 PRKCA	3.11e-05	13	111	3	ctd:C034047
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	B3GALNT1 GTPBP4 PARP2 POGZ LMNB1 EIF5 SPOP	3.13e-05	182	111	7	1951_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CUL1 PARP2 POGZ TRRAP ZFX LMNB1 EIF5	3.25e-05	183	111	7	7136_DN
Drug	ciclopirox	KRT16 PTGS1 PTGS2	3.95e-05	14	111	3	CID000002749
Drug	acemetacin	ACE PTGS1 PTGS2	3.95e-05	14	111	3	CID000001981
Drug	CGS 12970	ACE PTGS1 PTGS2	3.95e-05	14	111	3	CID000119553
Drug	AC1L1BH2	ACE PTGS1 PTGS2 UBA7 PRKCA	4.00e-05	78	111	5	CID000001436
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	BRINP3 MAN1C1 BAZ1B POGZ CPT1B FBXO9 PLA2G4C	4.12e-05	190	111	7	5271_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A	CYLD SETX MAN1C1 BAZ1B POGZ EIF5 SMARCA2	4.41e-05	192	111	7	2292_DN
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SWAP70 PDGFRA BAZ1B LMNB1 KCNJ4 RHOBTB2 PRKCA	5.02e-05	196	111	7	2217_UP
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; HL60; HT_HG-U133A	CYLD GTPBP4 STRN3 ZFX TMF1 METTL16 ABCC10	5.53e-05	199	111	7	2940_DN
Drug	firocoxib	PTGS1 PTGS2	7.04e-05	3	111	2	CID000208910
Drug	itazigrel	PTGS1 PTGS2	7.04e-05	3	111	2	CID000051087
Drug	nesodine	PTGS1 PTGS2	7.04e-05	3	111	2	CID006475455
Drug	imidaprilat	ACE PRKCA	7.04e-05	3	111	2	ctd:C078006
Drug	Meclofenamic acid	PTGS1 PTGS2	7.04e-05	3	111	2	DB00939
Drug	Acetylsalicylic acid	PTGS1 PTGS2	7.04e-05	3	111	2	DB00945
Drug	Salicyclic acid	PTGS1 PTGS2	7.04e-05	3	111	2	DB00936
Drug	Phenylbutazone	PTGS1 PTGS2	7.04e-05	3	111	2	DB00812
Drug	bis(dicyclohexylphosphino)methane	UBA7 SPAG17	7.04e-05	3	111	2	CID000618458
Drug	Etodolac	PTGS1 PTGS2	7.04e-05	3	111	2	DB00749
Drug	1a, 1b-dihomo-PGF2	PTGS1 PTGS2	7.04e-05	3	111	2	CID006443812
Drug	malabaricone C	PTGS1 PTGS2	7.04e-05	3	111	2	ctd:C071787
Drug	malabaricone B	PTGS1 PTGS2	7.04e-05	3	111	2	ctd:C071788
Drug	2-propionyloxybenzoic acid	PTGS1 PTGS2	7.04e-05	3	111	2	CID000095938
Drug	17-hydroxy-ent-kaur-15-en-19-oic acid	PTGS1 PTGS2	7.04e-05	3	111	2	CID000169654
Drug	AHR-10037	PTGS1 PTGS2	7.04e-05	3	111	2	CID000132843
Drug	kazinol B	PTGS1 PTGS2 PRKCA	7.30e-05	17	111	3	CID000480869
Drug	geldanamycin	SETX RBM26 MCM4 PTGS1 PTGS2 ZFX ZNF711 SMARCA2 METTL16	8.62e-05	371	111	9	ctd:C001277
Drug	Npc 17731	ACE PTGS1 PTGS2	1.03e-04	19	111	3	CID003081308
Drug	Asbestos, Crocidolite	CYLD IL32 SETX NAA15 RIPK2 PTGS2 ZFY CRYM FBXO9 RNF103 EIF5 PRKCA CACYBP RGL2 ABCC10 CDH13 SERTAD1	1.05e-04	1241	111	17	ctd:D017638
Drug	Pyrazoles	ACE PTGS1 PTGS2	1.21e-04	20	111	3	ctd:D011720
Drug	tert-butyl hydroperoxide	NAA15 ESS2 RIPK2 BAZ1B TRRAP NCAPG2 PTGS1 PTGS2 CRYM UBA7 LMNB1 EIF5 SMARCA2 PRKCA	1.26e-04	902	111	14	CID000006410
Drug	AI-122	PTGS1 PTGS2	1.40e-04	4	111	2	CID000134058
Drug	prostaglandin G2	PTGS1 PTGS2	1.40e-04	4	111	2	ctd:C038291
Drug	Resveratrol	PTGS1 PTGS2	1.40e-04	4	111	2	DB02709
Drug	oleanolic aldehyde	PTGS1 PTGS2	1.40e-04	4	111	2	CID005320280
Drug	triacontanol	PTGS1 PTGS2	1.40e-04	4	111	2	CID000068972
Drug	2-chloropyridine	PTGS1 PTGS2	1.40e-04	4	111	2	CID000007977
Drug	5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone	PTGS1 PTGS2	1.40e-04	4	111	2	ctd:C106876
Drug	12-HPETE	PTGS1 PTGS2	1.40e-04	4	111	2	ctd:C021201
Drug	sulfanilide	PTGS1 PTGS2	1.40e-04	4	111	2	CID000068517
Drug	Balsalazide	PTGS1 PTGS2	1.40e-04	4	111	2	DB01014
Drug	2-(6-carboxyhexyl)cyclopentanone hexylhydrazone	PTGS1 PTGS2	1.40e-04	4	111	2	CID000134996
Drug	anolignan B	PTGS1 PTGS2	1.40e-04	4	111	2	CID000072388
Drug	Flufenamic Acid	PTGS1 PTGS2	1.40e-04	4	111	2	DB02266
Drug	NSC-327431	PTGS1 PTGS2	1.40e-04	4	111	2	CID000362637
Drug	prantschimgin	PTGS1 PTGS2	1.40e-04	4	111	2	CID000025785
Drug	Niflumic Acid	PTGS1 PTGS2	1.40e-04	4	111	2	DB04552
Drug	C9H7BrO4	PTGS1 PTGS2	1.40e-04	4	111	2	CID000073922
Drug	8beta-prostane	PTGS1 PTGS2	1.40e-04	4	111	2	CID000107873
Drug	SC57666	PTGS1 PTGS2	1.40e-04	4	111	2	CID000443373
Drug	phenethyl isothiocyanate	KRT16 RIPK2 BAZ1B NCAPG2 PTGS2 EEF2KMT LMNB1 SF3A3 PRKCA	1.55e-04	401	111	9	ctd:C058305
Disease	Intellectual Disability	NAA15 GON4L CHD8 CHD3 POGZ TRRAP LINS1 RHOBTB2 DIAPH1 EPB41L1	4.61e-06	447	105	10	C3714756
Disease	Asthma, Occupational	PTGS1 PTGS2 PRKCA	5.16e-06	10	105	3	C0264423
Disease	gliosarcoma (biomarker_via_orthology)	PTGS1 PTGS2	1.25e-05	2	105	2	DOID:3071 (biomarker_via_orthology)
Disease	Schizophrenia	ESS2 ACE TRRAP ME2 PTGS1 PTGS2 MAGI2 PBRM1 PLA2G4C EIF5 SMARCA2 PRKCA PICK1	1.56e-05	883	105	13	C0036341
Disease	glioblastoma (biomarker_via_orthology)	PTGS1 PTGS2	7.49e-05	4	105	2	DOID:3068 (biomarker_via_orthology)
Disease	Nonorganic psychosis	ME2 PBRM1 PRKCA PICK1	1.10e-04	69	105	4	C0349204
Disease	Sezary Syndrome	IL32 CHD3 BRD9	1.20e-04	27	105	3	C0036920
Disease	Thymoma	CYLD PBRM1	1.25e-04	5	105	2	C0040100
Disease	Intestinal Polyps	PTGS1 PTGS2	1.25e-04	5	105	2	C0021846
Disease	CHARGE syndrome (implicated_via_orthology)	CHD8 CHD6	2.60e-04	7	105	2	DOID:0050834 (implicated_via_orthology)
Disease	ulcerative colitis (implicated_via_orthology)	PTGS1 PTGS2	2.60e-04	7	105	2	DOID:8577 (implicated_via_orthology)
Disease	Thymic Carcinoma	CYLD PBRM1	2.60e-04	7	105	2	C0205969
Disease	sarcoidosis (is_marker_for)	ACE PTGS2	3.46e-04	8	105	2	DOID:11335 (is_marker_for)
Disease	Prostatic Neoplasms	RAG1 CHD3 ACE PTGS2 TMF1 CHD6 SPOP MGA CDH13	3.61e-04	616	105	9	C0033578
Disease	Malignant neoplasm of prostate	RAG1 CHD3 ACE PTGS2 TMF1 CHD6 SPOP MGA CDH13	3.61e-04	616	105	9	C0376358
Disease	hearing impairment	CRYM DIAPH1 RPGR USH2A	4.23e-04	98	105	4	C1384666
Disease	renovascular hypertension (implicated_via_orthology)	ACE PTGS1	4.44e-04	9	105	2	DOID:1591 (implicated_via_orthology)
Disease	Psychotic Disorders	ME2 PBRM1 PRKCA PICK1	4.74e-04	101	105	4	C0033975
Disease	Creutzfeldt-Jakob disease (is_marker_for)	PTGS1 PTGS2	5.54e-04	10	105	2	DOID:11949 (is_marker_for)
Disease	Streptozotocin Diabetes	CPT1B ACE PTGS2 PRKCA	6.11e-04	108	105	4	C0038433
Disease	Diabetes Mellitus, Experimental	CPT1B ACE PTGS2 PRKCA	6.11e-04	108	105	4	C0011853
Disease	Alloxan Diabetes	CPT1B ACE PTGS2 PRKCA	6.11e-04	108	105	4	C0002152
Disease	Congestive heart failure	PDGFRA ACE PTGS1 PTGS2	6.54e-04	110	105	4	C0018802
Disease	Heart failure	PDGFRA ACE PTGS1 PTGS2	6.54e-04	110	105	4	C0018801
Disease	Left-Sided Heart Failure	PDGFRA ACE PTGS1 PTGS2	6.54e-04	110	105	4	C0023212
Disease	Heart Failure, Right-Sided	PDGFRA ACE PTGS1 PTGS2	6.54e-04	110	105	4	C0235527
Disease	Heart Decompensation	PDGFRA ACE PTGS1 PTGS2	6.54e-04	110	105	4	C1961112
Disease	Myocardial Failure	PDGFRA ACE PTGS1 PTGS2	6.54e-04	110	105	4	C1959583
Disease	Kidney Failure, Chronic	ACE PTGS1 PTGS2	6.74e-04	48	105	3	C0022661
Disease	Macrocephaly	CHD8 CHD3	6.76e-04	11	105	2	C0221355
Disease	pulmonary fibrosis (biomarker_via_orthology)	PDGFRA ACE PTGS2	7.60e-04	50	105	3	DOID:3770 (biomarker_via_orthology)
Disease	leukemia (is_implicated_in)	PDGFRA ACE	9.54e-04	13	105	2	DOID:1240 (is_implicated_in)
Disease	response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin	SMARCA2 CDH13	1.11e-03	14	105	2	EFO_0005400, GO_0036275, GO_1902518, GO_1902520
Disease	renal cell carcinoma (biomarker_via_orthology)	PTGS1 PTGS2	1.11e-03	14	105	2	DOID:4450 (biomarker_via_orthology)
Disease	Alzheimer's disease (implicated_via_orthology)	ACE PTGS1 PTGS2	1.11e-03	57	105	3	DOID:10652 (implicated_via_orthology)
Disease	hypertension (implicated_via_orthology)	RAG1 ACE PTGS2 PRKCA	1.15e-03	128	105	4	DOID:10763 (implicated_via_orthology)
Disease	BMI-adjusted adiponectin measurement	PBRM1 CDH13	1.28e-03	15	105	2	EFO_0007737
Disease	Global developmental delay	CHD3 TRRAP RHOBTB2 DIAPH1	1.33e-03	133	105	4	C0557874
Disease	Barrett Epithelium	PTGS2 CDH13	1.46e-03	16	105	2	C1258085
Disease	sarcoidosis (is_implicated_in)	ACE PTGS2	1.46e-03	16	105	2	DOID:11335 (is_implicated_in)
Disease	Barrett Esophagus	PTGS2 CDH13	1.46e-03	16	105	2	C0004763
Disease	Profound Mental Retardation	NAA15 GON4L CHD8 LINS1	1.56e-03	139	105	4	C0020796
Disease	Mental Retardation, Psychosocial	NAA15 GON4L CHD8 LINS1	1.56e-03	139	105	4	C0025363
Disease	Mental deficiency	NAA15 GON4L CHD8 LINS1	1.56e-03	139	105	4	C0917816
Disease	Bladder Neoplasm	KRT16 PTGS2 FBXW8 CHD6	1.60e-03	140	105	4	C0005695
Disease	Malignant neoplasm of urinary bladder	KRT16 PTGS2 FBXW8 CHD6	1.64e-03	141	105	4	C0005684
Disease	Psychoses, Substance-Induced	ACE PICK1	1.65e-03	17	105	2	C0033941
Disease	Gastric ulcer	PTGS1 PTGS2	1.85e-03	18	105	2	C0038358
Disease	congenital heart disease (implicated_via_orthology)	NAA15 CHD8 CHD6	1.93e-03	69	105	3	DOID:1682 (implicated_via_orthology)
Disease	bipolar disorder (is_marker_for)	PTGS1 PTGS2	2.06e-03	19	105	2	DOID:3312 (is_marker_for)
Disease	autism spectrum disorder (implicated_via_orthology)	NAA15 CHD8 POGZ CHD6	2.16e-03	152	105	4	DOID:0060041 (implicated_via_orthology)
Disease	end stage renal disease (implicated_via_orthology)	GTPBP4 ACE	2.29e-03	20	105	2	DOID:783 (implicated_via_orthology)
Disease	Psychoses, Drug	ACE PICK1	2.52e-03	21	105	2	C0033937
Disease	in situ carcinoma (is_marker_for)	PDGFRA PTGS2	2.52e-03	21	105	2	DOID:8719 (is_marker_for)
Disease	Esophageal Neoplasms	PTGS1 PTGS2 CDH13	2.74e-03	78	105	3	C0014859
Disease	Lung diseases	PDGFRA ACE PTGS2	2.74e-03	78	105	3	C0024115
Disease	Malignant neoplasm of esophagus	PTGS1 PTGS2 CDH13	2.74e-03	78	105	3	C0546837
Disease	hemoglobin change measurement	IFT43 CDH13	2.77e-03	22	105	2	EFO_0600027
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MFN1 FGD4	3.29e-03	24	105	2	DOID:10595 (implicated_via_orthology)
Disease	Intrahepatic Cholangiocarcinoma	PTGS2 PBRM1	3.29e-03	24	105	2	C0345905
Disease	nephrotic syndrome (implicated_via_orthology)	ACE PTGS2	3.29e-03	24	105	2	DOID:1184 (implicated_via_orthology)
Disease	Albuminuria	ACE PTGS2	3.29e-03	24	105	2	C0001925
Disease	Extrahepatic Cholangiocarcinoma	PTGS2 PBRM1	3.29e-03	24	105	2	C3805278

Protein segments in the cluster

Peptide	Gene	Start	Entry
AVDEMYDDLAVLEKD	BEST2	321	Q8NFU1
IGFETDLQDLEMKYL	BRINP3	486	Q76B58
LLRKGAYAAIMEEDD	CHD8	1306	Q9HCK8
ELEMNSELKDGAYLD	CTAGE3P	101	Q8IX95
DTESDINYLLKMALE	ACE	446	P12821
SVFGDLKSDEMELLY	BRD9	396	Q9H8M2
EIAEDYGELGMKLSE	BAZ1B	666	Q9UIG0
LELEMGDDYILDLQK	GTPBP4	401	Q9BZE4
AMFYGELAEDKDEIR	BTBD3	151	Q9Y2F9
EKVDDLLESYMGIRD	GIPC1	266	O14908
DDVLELYMGIRDIDL	GIPC2	251	Q8TF65
EGEEEVGLSYLMKEE	ANP32E	211	Q9BTT0
KYELIIEAQDMAGLD	CDH13	326	P55290
MLSELKDEYDDLAES	DIAPH1	906	O60610
KEELQEDGAKMLYAE	ASTE1	506	Q2TB18
DIVLLGYMLDDKDNS	ARMC12	111	Q5T9G4
LDDELMKEAVLYVDS	CRYM	236	Q14894
DILEGMRSQDLDDYL	RAG1	576	P15918
DTELDLYKKMQAGEE	RBM26	816	Q5T8P6
LEDTSLRLKDEMDLY	RAB11FIP4	461	Q86YS3
DTELLIGYLDSDMEA	PRDM5	116	Q9NQX1
DYTMTLLDLFEVEKD	PARP2	396	Q9UGN5
LYGMGKEELESEDFE	KCNJ4	271	P48050
EDDLVEMQGYKDKLS	MFN1	51	Q8IWA4
ADDEKMKELLRSYGA	ANKRD31	1261	Q8N7Z5
YALKATSELDLEMEA	PDGFRA	206	P16234
QAEEELLDMAVLKDY	MCM4	676	P33991
EYLERADAVLLMEAG	ABCC10	786	Q5T3U5
LDMEEKDYSEADGLS	EPB41L1	61	Q9H4G0
DELIKYMTEEDGVSL	EFCAB2	251	Q5VUJ9
LKMEEYDDVNLLTAD	PBRM1	101	Q86U86
DDDMLEAAKASLGIY	LINS1	446	Q8NG48
EDFMELEKSGALLES	MAGI2	161	Q86UL8
EYKMDLYVLRLAEDG	MAGI2	1166	Q86UL8
KLDEYLENEGKLMET	MGA	826	Q8IWI9
DGLQVKYDEDLEEMA	FAM185A	116	Q8N0U4
DMEISAYRKLLEGEE	LMNB1	371	P20700
DKMLALSLEDEHLLY	B3GALNT1	126	O75752
VAAAGDLMYLLKAED	FBXW8	361	Q8N3Y1
ELYEALAETLMAKES	EEF2KMT	91	Q96G04
LMNVLKKIYEDGDDD	CACYBP	191	Q9HB71
DEDLDRDLSYIKIMD	PFKFB4	206	Q16877
KKLLEIYEMLGEEED	FGD4	401	Q96M96
DLKLKDYGMDLIEVS	PMS2P11	201	Q13670
DLEMQIEGLKEELAY	KRT16	236	P08779
LMDALKEESEIIYDF	METTL16	166	Q86W50
KEMSAELEALYGDID	PTGS2	471	P35354
MAAELEELYGDIDAL	PTGS1	486	P23219
KSMDLSEYIIRGDDE	NAT10	956	Q9H0A0
LEDYEMAAKILEEFR	NAA15	161	Q9BXJ9
LDEDGASALFDMIEY	PPP1R37	146	O75864
LYTNDGDMEALEADL	PLA2G4C	91	Q9UP65
KEYLEAEENGDLERM	ESS2	66	Q96DF8
ILKEMYDADLLEEEV	EIF5	336	P55010
AEALELSEKLYLDMS	FHAD1	1236	B1AJZ9
MSSLAELEDDFKEGY	IL32	86	P24001
MEDLLDLDEELRYSL	IFT43	1	Q96FT9
LRKGAYGALMDEEDE	CHD6	956	Q8TD26
YIEDNDDDSKMADLL	FBXO9	146	Q9UK97
TKMLDLLEDFLDYEG	CHD3	1086	Q12873
LLEKLLEKYMDEDGE	CRISPLD1	31	Q9H336
DGEDLMDESVLKFYT	CUL1	106	Q13616
GTLAYDLKLDDMLDR	GON4L	261	Q3T8J9
IDSLDTLYLMELKEE	MAN1C1	221	Q9NR34
YDDLIDEFMKAITDR	ME2	231	P23368
AAALEIELEEDMYKG	DDX24	756	Q9GZR7
LDSDQKLLYGDVMLE	KRBOX5	21	Q7Z2F6
DMDFLLDEIDLLGKD	GADL1	506	Q6ZQY3
EVGEYLKMSLEDLHS	CYLD	911	Q9NQC7
SLEEEKYDMSGARLA	CASP14	6	P31944
GDLMEGELYSALKEE	RNF103	76	O00237
LEAVSMDGDKLDADY	SEC14L5	216	O43304
MDGDKLDADYIERCL	SEC14L5	221	O43304
AMDLYKALGAQDLTE	SAT2	136	Q96F10
LDDEEYYRMELLAKE	CPT1B	196	Q92523
QLEYLEALMGLEAEK	IFNE	116	Q86WN2
YELDLEESAVELMKD	PTCD2	141	Q8WV60
PDYLLDEMTKEAEID	RPGR	471	Q92834
SGLYVDEEDLMNAIK	USH2A	5171	O75445
MLDAASKDELENGYI	RGL2	441	O15211
TKLYDMIADLGDDEL	STRN3	371	Q13033
ELADVGSEYKEMEKL	NUGGC	746	Q68CJ6
LMAEDEEGYRKLIDQ	SMARCA2	506	P51531
YRDLKLDNVMLDSEG	PRKCA	461	P17252
MDKADELYDRVDGLL	PLEKHG4	421	Q58EX7
METDILESLEDLGYK	FAM98A	6	Q8NCA5
LLEAKESGYSDDEIM	POGZ	1191	Q7Z3K3
LGQFLEDMEAYAEDL	SMG1	361	Q96Q15
KFYDLFLMDLSEGEL	RHOBTB2	291	Q9BYZ6
ELEDDSISMGYKLQD	SLAIN1	256	Q8ND83
SMKAEIGDDDELYIV	SETX	76	Q7Z333
AEDADEVMGKYLSEK	SHCBP1L	136	Q9BZQ2
ISDLRMEDAGDYKAD	CD84	96	Q9UIB8
DYLEAREGMHLKDVD	TMEM151A	251	Q8N4L1
DEAELDYLMDVLVGT	SERTAD1	211	Q9UHV2
GMELLRDSDIEEYLS	SPAG17	1651	Q6Q759
FDYDLEESGEIKDML	NCAPG2	196	Q86XI2
LSKDDLMEAVTEYPD	CNGA2	551	Q16280
AEELRLDLEDVKNMY	TMF1	1066	P82094
MDALDASKLLDEELY	UBA7	1	P41226
LDKMADDLLAAADKY	SPOP	266	O43791
DALLSRDLIMKEDYE	RIPK2	461	O43353
DDSYLMKNDLAELRA	ZBED8	486	Q8IZ13
SKNLDKDMYGDDLEA	SNW1	451	Q13573
DYLDLDKMSLYSEAD	TRIM9	61	Q9C026
YLMISLDDAGKIEHD	ZFX	211	P17010
MEVSGNLRDLYDDKD	SF3A3	51	Q12874
ELEDMYLKLQEALED	SWAP70	421	Q9UH65
SLESMELDELALEKY	ZNF597	66	Q96LX8
EDYLMISLDDVGEKL	ZNF711	201	Q9Y462
KNADGYIDLDELKIM	TNNC1	106	P63316
MFADLDYDIEEDKLG	PICK1	1	Q9NRD5
DSLAELYSLLQEEDM	TRRAP	2746	Q9Y4A5
DYLMISLDDAGKIEH	ZFY	206	P08048
DMEIATYRKLLEGEE	KRT74	436	Q7RTS7